Thu, 29th Jul 2021 13:50
(ShareCast News) - British Land: Barclays reiterates overweight with a target price of 740p. GlaxoSmithKline: UBS reiterates neutral, 1600p target. Reckitt Benckiser: Jefferies reiterates buy with a 7750p target. GB Group: Berenberg reiterates buy with a 340p target. Great Portland Estates: Barcl
Read more(ShareCast News) - Shares in GB Group are down more than 12% after it reported a slower than expected roll-out of the GOV.UK Verify project, and despite expressing a confident FY outlook. It said first-half trading was robust with revenue of £37.5m, up 16% on the year. Organic growth was about 9%,
Read more(ShareCast News) - GB Group announced the appointment of Chris Clark as its new CEO on Thursday, replacing Richard Law, who is retiring from the board after 14 years as chief. The AIM-traded firm said it It is anticipated that Clark will join GBG on 1 April 2017, providing sufficient time to complet
Read more(ShareCast News) - GVC Holdings: Berenberg reiterates buy with a target price of 760p. Softcat: Citigroup reiterates buy, 410p target. GlaxoSmithKline: Jefferies downgrades to underperform with a 2300p target. Relx: UBS stays at buy with a 1600p target. GB Group: Citigroup starts coverage at buy
Read more(ShareCast News) - GB Group's finance and operations director Dave Wilson and his wife have sold around a quarter of their stake in the security and identity data group, not long after the outgoing chief executive also dumped a chunk of shares not long after they hit an all-time high in June. The Wi
Read more(ShareCast News) - GB Group chief executive Richard Law sold £2.2m worth of shares, the security and identity data group revealed in a statement overnight, as he prepares to step down from the board. Law and his wife, who remain the largest non-institutional shareholders in the company, sold 750,000
Read more(ShareCast News) - GBG, an identity intelligence specialist, agreed conditionally to buy IDscan Biometrics, an identification software provider, and raise up to £25m through a share placing on AIM. The deal consists of £37m cash on completion, with a maximum of £8m further if IDscan Biometrics reach
Read more